+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Swine Vaccines Market by Vaccine Type (Dna Vaccine, Inactivated Vaccine, Live Attenuated Vaccine), Animal Age (Breeders, Finishers, Growers), Route Of Administration, Packaging Type, End User, Disease Type, Distribution Channel - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 189 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6083723
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Swine Vaccines Market grew from USD 1.58 billion in 2024 to USD 1.70 billion in 2025. It is expected to continue growing at a CAGR of 7.63%, reaching USD 2.46 billion by 2030.

Setting the Stage for Evolution in Swine Vaccine Strategy with Emerging Health Threats Driving Urgent Preventive Innovation and Collaborative Responses

Over the past decade, global pork production has experienced robust growth, driven by evolving consumer preferences, rising incomes, and intensifying focus on animal welfare. Against this backdrop, swine diseases have posed a formidable threat to both herd health and economic stability, leading stakeholders to prioritize preventive measures over reactive treatments. As the industry grapples with challenges such as the spread of viral pathogens, antimicrobial resistance concerns, and shifting regulatory frameworks, the strategic importance of effective vaccination programs has never been clearer.

Innovations in immunology, biotechnology, and diagnostic tools have ushered in a new era of vaccine development, transforming traditional formulations into precision platforms capable of addressing emerging disease strains. In tandem, collaborative initiatives among producers, research institutions, and regulatory bodies have fostered accelerated approval pathways and enhanced post-market surveillance. These advances have broadened the toolkit available to swine health professionals, enabling more targeted interventions, optimized dosing regimens, and improved safety profiles.

This executive summary sets the scene for an in-depth exploration of pivotal industry shifts, from technological breakthroughs to trade policy impacts. It delves into granular segmentation insights, examines regional variations in demand and adoption, profiles leading corporate players driving innovation, and culminates with actionable strategic recommendations. By tracing the research methodology underpinning these insights, readers will appreciate the rigor and relevance of findings that are designed to inform critical investment, operational, and policy decisions in the fast-evolving swine vaccine landscape.

Harnessing Technological Breakthroughs and Regulatory Milestones to Drive Paradigm Shifts in Global Swine Vaccine Development and Distribution Strategies

Emerging technology platforms have revolutionized the swine vaccine landscape, shifting paradigms from broad-spectrum inactivated formulations to next-generation recombinant and DNA-based approaches that promise enhanced immunogenicity and reduced adverse reactions. Coupled with advances in adjuvant science and delivery systems, these innovations have expanded the developer’s toolkit, enabling more precise targeting of specific pathogens and facilitating single-dose administration strategies that improve compliance in large-scale production settings.

Regulatory dynamics have also undergone significant transformation, with authorities increasingly embracing streamlined approval processes for vaccines demonstrating strong safety and efficacy profiles. This shift has incentivized cross-sector collaborations, fostering partnerships between biotech startups and established animal health companies. Meanwhile, digital health tools such as remote monitoring systems and real-time data analytics have empowered producers to track vaccine performance, identify emerging disease patterns, and adjust immunization schedules dynamically.

As market participants navigate these transformative changes, a convergence of scientific, regulatory, and digital trends is recalibrating the competitive landscape. Agile organizations are leveraging integrated R&D networks, forging global alliances, and adopting flexible manufacturing models to respond swiftly to pathogen evolution. These seismic shifts underscore the importance of maintaining adaptive strategies that anticipate future challenges and capitalize on the expanding frontiers of vaccine science.

Evaluating the Multifaceted Consequences of 2025 United States Tariff Adjustments on Swine Vaccine Supply Chain Resilience and Market Access Dynamics

In 2025, newly instituted United States tariff measures have introduced a complex dynamic into the swine vaccine value chain, imposing elevated duties on key vaccine components and upstream materials. Manufacturers heavily reliant on international suppliers have encountered increased input costs, prompting a reevaluation of sourcing strategies and spurring interest in localized production capabilities. Suppliers positioned within preferential trade agreements have gained a competitive edge, compelling others to negotiate long-term contracts or explore alternative raw material origins.

These tariff adjustments have reverberated through distribution channels, affecting pricing structures for end users and raising questions about the sustainability of existing procurement models. In response, certain vaccine producers have accelerated investments in domestic manufacturing infrastructure, aiming to mitigate exposure to trade volatility. Others have pursued co-manufacturing alliances to access tariff-exempt jurisdictions, while forward-looking organizations are exploring multi-currency invoicing arrangements to buffer against currency fluctuations tied to trade disputes.

Despite the pressures introduced by these policies, the quest for efficient vaccine delivery remains undeterred. Stakeholders are recalibrating their strategic roadmaps by diversifying supplier portfolios, optimizing inventory management through predictive analytics, and engaging in policy dialogue to seek exemptions for critical animal health imports. These adaptive maneuvers offer valuable case studies in resilience and highlight the imperative of agile planning in an environment marked by shifting trade landscapes.

Decoding Diverse Segmentation Parameters with Strategic Depth to Uncover Nuanced Trends Shaping the Complex Swine Vaccine Market Landscape

Navigating the complexities of swine vaccine segmentation requires a nuanced appreciation of how diverse parameters intersect to shape demand and influence product development. When considering vaccine type segmentation, distinctions between DNA vaccine platforms, inactivated formulations, live attenuated constructs, recombinant innovations, subunit designs, and toxoid-based solutions reveal differentiated pathways to eliciting protective immune responses. Each platform carries unique production requirements, safety considerations, and cost structures that inform both research priorities and go-to-market strategies.

Similarly, segmentation by animal age underscores how immunization protocols must be tailored to the physiological and production cycle differences among breeders-including both boars and sows-as well as finishers, growers, piglets, and weaners. This age-based stratification informs dosage regimens, formulation choices, and scheduling logistics, prompting manufacturers to develop age-specific vaccine portfolios. In parallel, route of administration considerations-from traditional injection routes to nasal sprays and oral formulations-further influence ease of deployment and uptake in diverse farm environments.

Packaging format segmentation reveals preference patterns for multi-dose bottles, pre-filled syringes, and vials, each offering distinct benefits in terms of dosage accuracy, cold-chain requirements, and waste minimization. End user segmentation spans commercial farms, research institutes, veterinary clinics, and veterinary hospitals, each presenting varying procurement processes and volume demands. Analyzing disease type segmentation-targeting pathogens such as classical swine fever, erysipelas, Mycoplasma pneumonia, porcine circovirus, porcine reproductive and respiratory syndrome, and swine influenza-highlights the strategic prioritization of vaccine pipelines. Finally, distribution channel segmentation illuminates the emerging role of online pharmacies, driven by company websites and e-commerce platforms, alongside established veterinary clinics and hospitals, in ensuring timely access to critical immunization products.

Unearthing Regional Distinctions and Strategic Imperatives Revealing Key Drivers and Challenges across Americas, EMEA, and Asia-Pacific in Swine Vaccination

Regional disparities in swine vaccine adoption and development underscore the importance of tailoring strategies to localized drivers and constraints. In the Americas, a mature infrastructure supported by advanced research institutions and integrated production systems fosters early adoption of novel vaccine platforms. Cost-benefit analyses in this region emphasize productivity gains and biosecurity enhancements, driving significant uptake of next-generation immunization solutions.

Within Europe, Middle East and Africa, regulatory harmonization efforts have streamlined cross-border approvals, yet varying disease prevalence patterns and fragmented production scales require regionally calibrated distribution frameworks. Stakeholders in Western Europe leverage strong public-private partnerships to fund vaccine R&D, while producers in parts of Africa contend with logistical challenges that influence product stability and cold-chain management.

Asia-Pacific presents a mosaic of high-growth opportunities, where rising pork consumption and government-backed disease eradication programs stimulate demand. Rapidly expanding commercial farms coexist with smallholder operations, prompting vaccine developers to balance scale-up initiatives with affordability imperatives. Initiatives to localize manufacturing and invest in digital outreach have yielded resilience against supply disruptions, positioning the region as a critical frontier for both established players and emerging entrants seeking long-term growth.

Revealing the Competitive Maneuvers and Innovation Portfolios of Leading Global Players Driving Advancement in Swine Vaccine Research and Commercialization

Leading participants in the swine vaccine arena are deploying multifaceted strategies to secure competitive advantage. Established animal health conglomerates focus on bolstering their pipelines through in-house R&D, targeting pathogenic threat areas such as porcine reproductive and respiratory syndrome and porcine circovirus. Simultaneously, these firms are pursuing strategic acquisitions of biotech startups specializing in mRNA and DNA vaccine platforms to complement existing live attenuated and recombinant offerings.

At the same time, innovative biotech enterprises are forging collaborative alliances with academic centers and contract manufacturing organizations to accelerate clinical development and scale up production capabilities. By leveraging open innovation models, these agile players can rapidly pivot in response to emerging disease patterns, deploying pilot manufacturing runs and proof-of-concept studies within compressed timelines.

Meanwhile, a growing cohort of regional companies in Asia-Pacific and Latin America is investing in local production facilities to address tariff challenges and meet region-specific strain requirements. These organizations are also adopting digital distribution channels, partnering with veterinary networks to optimize cold-chain logistics and deliver targeted training programs for farm personnel. Collectively, these strategic maneuvers illustrate a dynamic competitive environment defined by product diversification, geographic expansion, and technology integration.

Presenting Actionable Strategic Recommendations to Enable Industry Leaders to Strengthen Swine Vaccine Development, Supply Chain Resilience and Collaboration

Industry leaders should prioritize a tiered innovation roadmap that balances foundational vaccine platforms with investment in next-generation technologies. By allocating resources to DNA, recombinant, and mRNA modalities alongside traditional attenuated and inactivated formulations, organizations can hedge against pathogen evolution and regulatory uncertainties. This approach also supports the development of multivalent vaccines capable of targeting co-circulating swine diseases, enhancing on-farm efficiency and herd health outcomes.

In parallel, strategic alliances with raw material suppliers and contract manufacturers can mitigate the impact of external tariff pressures while enabling flexible production scaling. Establishing regional hubs in tariff-advantaged jurisdictions will serve to shorten supply chains, reduce lead times, and strengthen continuity of supply. In tandem, digital solutions for predictive demand planning, traceability, and cold-chain monitoring will unlock operational efficiencies and foster greater transparency across distribution networks.

Finally, fostering deeper engagement with regulatory authorities and industry associations can facilitate accelerated review pathways and align standards across key geographies. By participating in joint consortia and open-data initiatives, stakeholders can contribute to evidence repositories that inform policy decisions and build trust in innovative immunization approaches. These concerted efforts will position industry leaders to navigate the evolving landscape with agility and resilience.

Outlining a Robust and Transparent Research Methodology Leveraging Primary and Secondary Data Sources to Ensure Rigor and Credibility in Insights Generation

This research draws upon a comprehensive methodology designed to ensure the validity, reliability, and relevance of insights. Primary data was collected through structured interviews with key opinion leaders, including veterinary experts, production managers, and regulatory officials, providing firsthand perspectives on disease prevalence, vaccine performance, and adoption barriers. In parallel, an extensive secondary research process involved the systematic review of scientific publications, regulatory filings, corporate disclosures, and trade publications to map technological advancements and policy shifts.

Data triangulation techniques were applied to reconcile discrepancies and validate trends across multiple sources. Statistical analyses, including trend detection algorithms and correlation assessments, were employed to identify underlying drivers and quantify relationships between variables. Quality assurance protocols, such as peer review and methodological audits, were instituted at each phase to uphold analytical rigor.

Geographic coverage spanned major swine-producing regions, ensuring that regional nuances in disease patterns, regulatory landscapes, and market infrastructures were accurately captured. Ethical considerations, including data confidentiality and stakeholder consent, were rigorously maintained. This robust research framework underpins the strategic recommendations and insights presented throughout the executive summary.

Drawing Conclusive Insights to Illuminate the Strategic Imperative of Adaptive and Integrated Approaches in the Evolving Swine Vaccine Ecosystem

The analysis elucidates a swine vaccine ecosystem in transition, where scientific breakthroughs, trade policy shifts, and evolving farm practices are converging to redefine preventive health strategies. Adaptive innovation pipelines that integrate traditional and novel vaccine platforms will be essential for addressing emergent disease threats and meeting the diverse immunization needs of breeders, finishers, growers, piglets, and weaners.

Regional strategies must be tailored to the unique regulatory environments and production dynamics of the Americas, EMEA, and Asia-Pacific, balancing the demands of large-scale commercial operations with the realities of smallholder contexts. Competitive positioning will hinge on the ability to orchestrate cross-sector collaborations, optimize supply chain configurations, and harness digital tools for real-time monitoring and distribution efficiency.

Ultimately, the path forward demands strategic agility, underpinned by rigorous data-driven decision-making and proactive stakeholder engagement. Organizations that embrace a holistic perspective-fusing advanced vaccine science with robust operational frameworks-will be best positioned to secure sustainable growth and enhance swine herd health in an era of unprecedented challenges and opportunities.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Vaccine Type
    • Dna Vaccine
    • Inactivated Vaccine
    • Live Attenuated Vaccine
    • Recombinant Vaccine
    • Subunit Vaccine
    • Toxoid Vaccine
  • Animal Age
    • Breeders
      • Boars
      • Sows
    • Finishers
    • Growers
    • Piglets
    • Weaners
  • Route Of Administration
    • Injection
    • Nasal
    • Oral
  • Packaging Type
    • Multi Dose Bottle
    • Pre Filled Syringe
    • Vial
  • End User
    • Commercial Farms
    • Research Institutes
    • Veterinary Clinics
    • Veterinary Hospitals
  • Disease Type
    • Classical Swine Fever
    • Erysipelas
    • Mycoplasma Pneumonia
    • Porcine Circovirus
    • Porcine Reproductive And Respiratory Syndrome
    • Swine Influenza
  • Distribution Channel
    • Online Pharmacies
      • Company Websites
      • E Commerce Platforms
    • Veterinary Clinics
    • Veterinary Hospitals
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report delves into recent significant developments and analyzes trends in each of the following companies:
  • Zoetis Inc.
  • Merck & Co., Inc.
  • Boehringer Ingelheim Animal Health GmbH
  • Elanco Animal Health Incorporated
  • Ceva Santé Animale SAS
  • Virbac S.A.
  • Vetoquinol S.A.
  • HIPRA, S.A.
  • Phibro Animal Health Corporation
  • IDT Biologika GmbH

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Innovations in mRNA vaccine platforms for broad-spectrum swine influenza protection
5.2. Adoption of single-dose combination vaccines targeting PRRS and porcine circovirus type 2 to reduce farm vaccination stress
5.3. Expansion of thermostable vaccine formulations for improved distribution in emerging Asian and Latin American swine markets
5.4. Integration of recombinant viral vector technologies to accelerate immune response against classical swine fever
5.5. Implementation of on-farm rapid diagnostic tools to guide targeted swine vaccine administration protocols
5.6. Regulatory approval pathways streamlining for gene-deleted live attenuated vaccines in major pork producing regions
5.7. Investment trends in precision livestock farming combining sensor data with vaccination scheduling for optimized herd health
5.8. Public-private partnerships driving research on universal vaccines against emerging porcine coronaviruses and influenza strains
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Swine Vaccines Market, by Vaccine Type
8.1. Introduction
8.2. Dna Vaccine
8.3. Inactivated Vaccine
8.4. Live Attenuated Vaccine
8.5. Recombinant Vaccine
8.6. Subunit Vaccine
8.7. Toxoid Vaccine
9. Swine Vaccines Market, by Animal Age
9.1. Introduction
9.2. Breeders
9.2.1. Boars
9.2.2. Sows
9.3. Finishers
9.4. Growers
9.5. Piglets
9.6. Weaners
10. Swine Vaccines Market, by Route Of Administration
10.1. Introduction
10.2. Injection
10.3. Nasal
10.4. Oral
11. Swine Vaccines Market, by Packaging Type
11.1. Introduction
11.2. Multi Dose Bottle
11.3. Pre Filled Syringe
11.4. Vial
12. Swine Vaccines Market, by End User
12.1. Introduction
12.2. Commercial Farms
12.3. Research Institutes
12.4. Veterinary Clinics
12.5. Veterinary Hospitals
13. Swine Vaccines Market, by Disease Type
13.1. Introduction
13.2. Classical Swine Fever
13.3. Erysipelas
13.4. Mycoplasma Pneumonia
13.5. Porcine Circovirus
13.6. Porcine Reproductive And Respiratory Syndrome
13.7. Swine Influenza
14. Swine Vaccines Market, by Distribution Channel
14.1. Introduction
14.2. Online Pharmacies
14.2.1. Company Websites
14.2.2. E Commerce Platforms
14.3. Veterinary Clinics
14.4. Veterinary Hospitals
15. Americas Swine Vaccines Market
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. Argentina
16. Europe, Middle East & Africa Swine Vaccines Market
16.1. Introduction
16.2. United Kingdom
16.3. Germany
16.4. France
16.5. Russia
16.6. Italy
16.7. Spain
16.8. United Arab Emirates
16.9. Saudi Arabia
16.10. South Africa
16.11. Denmark
16.12. Netherlands
16.13. Qatar
16.14. Finland
16.15. Sweden
16.16. Nigeria
16.17. Egypt
16.18. Turkey
16.19. Israel
16.20. Norway
16.21. Poland
16.22. Switzerland
17. Asia-Pacific Swine Vaccines Market
17.1. Introduction
17.2. China
17.3. India
17.4. Japan
17.5. Australia
17.6. South Korea
17.7. Indonesia
17.8. Thailand
17.9. Philippines
17.10. Malaysia
17.11. Singapore
17.12. Vietnam
17.13. Taiwan
18. Competitive Landscape
18.1. Market Share Analysis, 2024
18.2. FPNV Positioning Matrix, 2024
18.3. Competitive Analysis
18.3.1. Zoetis Inc.
18.3.2. Merck & Co., Inc.
18.3.3. Boehringer Ingelheim Animal Health GmbH
18.3.4. Elanco Animal Health Incorporated
18.3.5. Ceva Santé Animale SAS
18.3.6. Virbac S.A.
18.3.7. Vetoquinol S.A.
18.3.8. HIPRA, S.A.
18.3.9. Phibro Animal Health Corporation
18.3.10. IDT Biologika GmbH
19. ResearchAI
20. ResearchStatistics
21. ResearchContacts
22. ResearchArticles
23. Appendix
List of Figures
FIGURE 1. SWINE VACCINES MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL SWINE VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL SWINE VACCINES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL SWINE VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL SWINE VACCINES MARKET SIZE, BY VACCINE TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL SWINE VACCINES MARKET SIZE, BY VACCINE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL SWINE VACCINES MARKET SIZE, BY ANIMAL AGE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL SWINE VACCINES MARKET SIZE, BY ANIMAL AGE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL SWINE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL SWINE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL SWINE VACCINES MARKET SIZE, BY PACKAGING TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL SWINE VACCINES MARKET SIZE, BY PACKAGING TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL SWINE VACCINES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL SWINE VACCINES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL SWINE VACCINES MARKET SIZE, BY DISEASE TYPE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL SWINE VACCINES MARKET SIZE, BY DISEASE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL SWINE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 18. GLOBAL SWINE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS SWINE VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS SWINE VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES SWINE VACCINES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES SWINE VACCINES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA SWINE VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA SWINE VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC SWINE VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC SWINE VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. SWINE VACCINES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. SWINE VACCINES MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 29. SWINE VACCINES MARKET: RESEARCHAI
FIGURE 30. SWINE VACCINES MARKET: RESEARCHSTATISTICS
FIGURE 31. SWINE VACCINES MARKET: RESEARCHCONTACTS
FIGURE 32. SWINE VACCINES MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. SWINE VACCINES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL SWINE VACCINES MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL SWINE VACCINES MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL SWINE VACCINES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL SWINE VACCINES MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL SWINE VACCINES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL SWINE VACCINES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL SWINE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL SWINE VACCINES MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL SWINE VACCINES MARKET SIZE, BY DNA VACCINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL SWINE VACCINES MARKET SIZE, BY DNA VACCINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL SWINE VACCINES MARKET SIZE, BY INACTIVATED VACCINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL SWINE VACCINES MARKET SIZE, BY INACTIVATED VACCINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL SWINE VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL SWINE VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL SWINE VACCINES MARKET SIZE, BY RECOMBINANT VACCINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL SWINE VACCINES MARKET SIZE, BY RECOMBINANT VACCINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL SWINE VACCINES MARKET SIZE, BY SUBUNIT VACCINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL SWINE VACCINES MARKET SIZE, BY SUBUNIT VACCINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL SWINE VACCINES MARKET SIZE, BY TOXOID VACCINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL SWINE VACCINES MARKET SIZE, BY TOXOID VACCINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL SWINE VACCINES MARKET SIZE, BY ANIMAL AGE, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL SWINE VACCINES MARKET SIZE, BY ANIMAL AGE, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL SWINE VACCINES MARKET SIZE, BY BREEDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL SWINE VACCINES MARKET SIZE, BY BREEDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL SWINE VACCINES MARKET SIZE, BY BOARS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL SWINE VACCINES MARKET SIZE, BY BOARS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL SWINE VACCINES MARKET SIZE, BY SOWS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL SWINE VACCINES MARKET SIZE, BY SOWS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL SWINE VACCINES MARKET SIZE, BY BREEDERS, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL SWINE VACCINES MARKET SIZE, BY BREEDERS, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL SWINE VACCINES MARKET SIZE, BY FINISHERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL SWINE VACCINES MARKET SIZE, BY FINISHERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL SWINE VACCINES MARKET SIZE, BY GROWERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL SWINE VACCINES MARKET SIZE, BY GROWERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL SWINE VACCINES MARKET SIZE, BY PIGLETS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL SWINE VACCINES MARKET SIZE, BY PIGLETS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL SWINE VACCINES MARKET SIZE, BY WEANERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL SWINE VACCINES MARKET SIZE, BY WEANERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL SWINE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL SWINE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL SWINE VACCINES MARKET SIZE, BY INJECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL SWINE VACCINES MARKET SIZE, BY INJECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL SWINE VACCINES MARKET SIZE, BY NASAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL SWINE VACCINES MARKET SIZE, BY NASAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL SWINE VACCINES MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL SWINE VACCINES MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL SWINE VACCINES MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL SWINE VACCINES MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL SWINE VACCINES MARKET SIZE, BY MULTI DOSE BOTTLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL SWINE VACCINES MARKET SIZE, BY MULTI DOSE BOTTLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL SWINE VACCINES MARKET SIZE, BY PRE FILLED SYRINGE, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL SWINE VACCINES MARKET SIZE, BY PRE FILLED SYRINGE, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL SWINE VACCINES MARKET SIZE, BY VIAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL SWINE VACCINES MARKET SIZE, BY VIAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL SWINE VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL SWINE VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL SWINE VACCINES MARKET SIZE, BY COMMERCIAL FARMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL SWINE VACCINES MARKET SIZE, BY COMMERCIAL FARMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL SWINE VACCINES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL SWINE VACCINES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL SWINE VACCINES MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL SWINE VACCINES MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL SWINE VACCINES MARKET SIZE, BY VETERINARY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL SWINE VACCINES MARKET SIZE, BY VETERINARY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL SWINE VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL SWINE VACCINES MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL SWINE VACCINES MARKET SIZE, BY CLASSICAL SWINE FEVER, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL SWINE VACCINES MARKET SIZE, BY CLASSICAL SWINE FEVER, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL SWINE VACCINES MARKET SIZE, BY ERYSIPELAS, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL SWINE VACCINES MARKET SIZE, BY ERYSIPELAS, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL SWINE VACCINES MARKET SIZE, BY MYCOPLASMA PNEUMONIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL SWINE VACCINES MARKET SIZE, BY MYCOPLASMA PNEUMONIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL SWINE VACCINES MARKET SIZE, BY PORCINE CIRCOVIRUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL SWINE VACCINES MARKET SIZE, BY PORCINE CIRCOVIRUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL SWINE VACCINES MARKET SIZE, BY PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL SWINE VACCINES MARKET SIZE, BY PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL SWINE VACCINES MARKET SIZE, BY SWINE INFLUENZA, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL SWINE VACCINES MARKET SIZE, BY SWINE INFLUENZA, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL SWINE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL SWINE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL SWINE VACCINES MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL SWINE VACCINES MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL SWINE VACCINES MARKET SIZE, BY COMPANY WEBSITES, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL SWINE VACCINES MARKET SIZE, BY COMPANY WEBSITES, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL SWINE VACCINES MARKET SIZE, BY E COMMERCE PLATFORMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL SWINE VACCINES MARKET SIZE, BY E COMMERCE PLATFORMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL SWINE VACCINES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL SWINE VACCINES MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL SWINE VACCINES MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL SWINE VACCINES MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL SWINE VACCINES MARKET SIZE, BY VETERINARY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL SWINE VACCINES MARKET SIZE, BY VETERINARY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS SWINE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS SWINE VACCINES MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS SWINE VACCINES MARKET SIZE, BY ANIMAL AGE, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS SWINE VACCINES MARKET SIZE, BY ANIMAL AGE, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS SWINE VACCINES MARKET SIZE, BY BREEDERS, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS SWINE VACCINES MARKET SIZE, BY BREEDERS, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS SWINE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS SWINE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS SWINE VACCINES MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS SWINE VACCINES MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS SWINE VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS SWINE VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS SWINE VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS SWINE VACCINES MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS SWINE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS SWINE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS SWINE VACCINES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS SWINE VACCINES MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS SWINE VACCINES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS SWINE VACCINES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES SWINE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES SWINE VACCINES MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES SWINE VACCINES MARKET SIZE, BY ANIMAL AGE, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES SWINE VACCINES MARKET SIZE, BY ANIMAL AGE, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES SWINE VACCINES MARKET SIZE, BY BREEDERS, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES SWINE VACCINES MARKET SIZE, BY BREEDERS, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES SWINE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES SWINE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES SWINE VACCINES MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES SWINE VACCINES MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES SWINE VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES SWINE VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES SWINE VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES SWINE VACCINES MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES SWINE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES SWINE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES SWINE VACCINES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES SWINE VACCINES MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES SWINE VACCINES MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES SWINE VACCINES MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 135. CANADA SWINE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 136. CANADA SWINE VACCINES MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 137. CANADA SWINE VACCINES MARKET SIZE, BY ANIMAL AGE, 2018-2024 (USD MILLION)
TABLE 138. CANADA SWINE VACCINES MARKET SIZE, BY ANIMAL AGE, 2025-2030 (USD MILLION)
TABLE 139. CANADA SWINE VACCINES MARKET SIZE, BY BREEDERS, 2018-2024 (USD MILLION)
TABLE 140. CANADA SWINE VACCINES MARKET SIZE, BY BREEDERS, 2025-2030 (USD MILLION)
TABLE 141. CANADA SWINE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 142. CANADA SWINE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 143. CANADA SWINE VACCINES MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 144. CANADA SWINE VACCINES MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 145. CANADA SWINE VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 146. CANADA SWINE VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 147. CANADA SWINE VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
TABLE 148. CANADA SWINE VACCINES MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
TABLE 149. CANADA SWINE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 150. CANADA SWINE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 151. CANADA SWINE VACCINES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 152. CANADA SWINE VACCINES MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 153. MEXICO SWINE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 154. MEXICO SWINE VACCINES MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 155. MEXICO SWINE VACCINES MARKET SIZE, BY ANIMAL AGE, 2018-2024 (USD MILLION)
TABLE 156. MEXICO SWINE VACCINES MARKET SIZE, BY ANIMAL AGE, 2025-2030 (USD MILLION)
TABLE 157. MEXICO SWINE VACCINES MARKET SIZE, BY BREEDERS, 2018-2024 (USD MILLION)
TABLE 158. MEXICO SWINE VACCINES MARKET SIZE, BY BREEDERS, 2025-2030 (USD MILLION)
TABLE 159. MEXICO SWINE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 160. MEXICO SWINE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 161. MEXICO SWINE VACCINES MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 162. MEXICO SWINE VACCINES MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 163. MEXICO SWINE VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 164. MEXICO SWINE VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 165. MEXICO SWINE VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
TABLE 166. MEXICO SWINE VACCINES MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
TABLE 167. MEXICO SWINE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 168. MEXICO SWINE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 169. MEXICO SWINE VACCINES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 170. MEXICO SWINE VACCINES MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 171. BRAZIL SWINE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 172. BRAZIL SWINE VACCINES MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 173. BRAZIL SWINE VACCINES MARKET SIZE, BY ANIMAL AGE, 2018-2024 (USD MILLION)
TABLE 174. BRAZIL SWINE VACCINES MARKET SIZE, BY ANIMAL AGE, 2025-2030 (USD MILLION)
TABLE 175. BRAZIL SWINE VACCINES MARKET SIZE, BY BREEDERS, 2018-2024 (USD MILLION)
TABLE 176. BRAZIL SWINE VACCINES MARKET SIZE, BY BREEDERS, 2025-2030 (USD MILLION)
TABLE 177. BRAZIL SWINE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 178. BRAZIL SWINE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 179. BRAZIL SWINE VACCINES MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 180. BRAZIL SWINE VACCINES MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 181. BRAZIL SWINE VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 182. BRAZIL SWINE VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 183. BRAZIL SWINE VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
TABLE 184. BRAZIL SWINE VACCINES MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
TABLE 185. BRAZIL SWINE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 186. BRAZIL SWINE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 187. BRAZIL SWINE VACCINES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 188. BRAZIL SWINE VACCINES MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 189. ARGENTINA SWINE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 190. ARGENTINA SWINE VACCINES MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 191. ARGENTINA SWINE VACCINES MARKET SIZE, BY ANIMAL AGE, 2018-2024 (USD MILLION)
TABLE 192. ARGENTINA SWINE VACCINES MARKET SIZE, BY ANIMAL AGE, 2025-2030 (USD MILLION)
TABLE 193. ARGENTINA SWINE VACCINES MARKET SIZE, BY BREEDERS, 2018-2024 (USD MILLION)
TABLE 194. ARGENTINA SWINE VACCINES MARKET SIZE, BY BREEDERS, 2025-2030 (USD MILLION)
TABLE 195. ARGENTINA SWINE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 196. ARGENTINA SWINE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 197. ARGENTINA SWINE VACCINES MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 198. ARGENTINA SWINE VACCINES MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 199. ARGENTINA SWINE VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 200. ARGENTINA SWINE VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 201. ARGENTINA SWINE VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
TABLE 202. ARGENTINA SWINE VACCINES MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
TABLE 203. ARGENTINA SWINE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 204. ARGENTINA SWINE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 205. ARGENTINA SWINE VACCINES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 206. ARGENTINA SWINE VACCINES MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA SWINE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA SWINE VACCINES MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 209. EUROPE, MIDDLE EAST & AFRICA SWINE VACCINES MARKET SIZE, BY ANIMAL AGE, 2018-2024 (USD MILLION)
TABLE 210. EUROPE, MIDDLE EAST & AFRICA SWINE VACCINES MARKET SIZE, BY ANIMAL AGE, 2025-2030 (USD MILLION)
TABLE 211. EUROPE, MIDDLE EAST & AFRICA SWINE VACCINES MARKET SIZE, BY BREEDERS, 2018-2024 (USD MILLION)
TABLE 212. EUROPE, MIDDLE EAST & AFRICA SWINE VACCINES MARKET SIZE, BY BREEDERS, 2025-2030 (USD MILLION)
TABLE 213. EUROPE, MIDDLE EAST & AFRICA SWINE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 214. EUROPE, MIDDLE EAST & AFRICA SWINE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 215. EUROPE, MIDDLE EAST & AFRICA SWINE VACCINES MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 216. EUROPE, MIDDLE EAST & AFRICA SWINE VACCINES MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA SWINE VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA SWINE VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA SWINE VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA SWINE VACCINES MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA SWINE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA SWINE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 223. EUROPE, MIDDLE EAST & AFRICA SWINE VACCINES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA SWINE VACCINES MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 225. EUROPE, MIDDLE EAST & AFRICA SWINE VACCINES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 226. EUROPE, MIDDLE EAST & AFRICA SWINE VACCINES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 227. UNITED KINGDOM SWINE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 228. UNITED KINGDOM SWINE VACCINES MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 229. UNITED KINGDOM SWINE VACCINES MARKET SIZE, BY ANIMAL AGE, 2018-2024 (USD MILLION)
TABLE 230. UNITED KINGDOM SWINE VACCINES MARKET SIZE, BY ANIMAL AGE, 2025-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM SWINE VACCINES MARKET SIZE, BY BREEDERS, 2018-2024 (USD MILLION)
TABLE 232. UNITED KINGDOM SWINE VACCINES MARKET SIZE, BY BREEDERS, 2025-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM SWINE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 234. UNITED KINGDOM SWINE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM SWINE VACCINES MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 236. UNITED KINGDOM SWINE VACCINES MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 237. UNITED KINGDOM SWINE VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 238. UNITED KINGDOM SWINE VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 239. UNITED KINGDOM SWINE VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
TABLE 240. UNITED KINGDOM SWINE VACCINES MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
TABLE 241. UNITED KINGDOM SWINE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 242. UNITED KINGDOM SWINE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 243. UNITED KINGDOM SWINE VACCINES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 244. UNITED KINGDOM SWINE VACCINES MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 245. GERMANY SWINE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 246. GERMANY SWINE VACCINES MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 247. GERMANY SWINE VACCINES MARKET SIZE, BY ANIMAL AGE, 2018-2024 (USD MILLION)
TABLE 248. GERMANY SWINE VACCINES MARKET SIZE, BY ANIMAL AGE, 2025-2030 (USD MILLION)
TABLE 249. GERMANY SWINE VACCINES MARKET SIZE, BY BREEDERS, 2018-2024 (USD MILLION)
TABLE 250. GERMANY SWINE VACCINES MARKET SIZE, BY BREEDERS, 2025-2030 (USD MILLION)
TABLE 251. GERMANY SWINE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 252. GERMANY SWINE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 253. GERMANY SWINE VACCINES MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 254. GERMANY SWINE VACCINES MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 255. GERMANY SWINE VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 256. GERMANY SWINE VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 257. GERMANY SWINE VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
TABLE 258. GERMANY SWINE VACCINES MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
TABLE 259. GERMANY SWINE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 260. GERMANY SWINE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 261. GERMANY SWINE VACCINES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 262. GERMANY SWINE VACCINES MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 263. FRANCE SWINE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 264. FRANCE SWINE VACCINES MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 265. FRANCE SWINE VACCINES MARKET SIZE, BY ANIMAL AGE, 2018-2024 (USD MILLION)
TABLE 266. FRANCE SWINE VACCINES MARKET SIZE, BY ANIMAL AGE, 2025-2030 (USD MILLION)
TABLE 267. FRANCE SWINE VACCINES MARKET SIZE, BY BREEDERS, 2018-2024 (USD MILLION)
TABLE 268. FRANCE SWINE VACCINES MARKET SIZE, BY BREEDERS, 2025-2030 (USD MILLION)
TABLE 269. FRANCE SWINE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 270. FRANCE SWINE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 271. FRANCE SWINE VACCINES MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 272. FRANCE SWINE VACCINES MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 273. FRANCE SWINE VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 274. FRANCE SWINE VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 275. FRANCE SWINE VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
TABLE 276. FRANCE SWINE VACCINES MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
TABLE 277. FRANCE SWINE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 278. FRANCE SWINE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 279. FRANCE SWINE VACCINES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 280. FRANCE SWINE VACCINES MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 281. RUSSIA SWINE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 282. RUSSIA SWINE VACCINES MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 283. RUSSIA SWINE VACCINES MARKET SIZE, BY ANIMAL AGE, 2018-2024 (USD MILLION)
TABLE 284. RUSSIA SWINE VACCINES MARKET SIZE, BY ANIMAL AGE, 2025-2030 (USD MILLION)
TABLE 285. RUSSIA SWINE VACCINES MARKET SIZE, BY BREEDERS, 2018-2024 (USD MILLION)
TABLE 286. RUSSIA SWINE VACCINES MARKET SIZE, BY BREEDERS, 2025-2030 (USD MILLION)
TABLE 287. RUSSIA SWINE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 288. RUSSIA SWINE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 289. RUSSIA SWINE VACCINES MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 290. RUSSIA SWINE VACCINES MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 291. RUSSIA SWINE VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 292. RUSSIA SWINE VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 293. RUSSIA SWINE VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
TABLE 294. RUSSIA SWINE VACCINES MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
TABLE 295. RUSSIA SWINE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 296. RUSSIA SWINE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 297. RUSSIA SWINE VACCINES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 298. RUSSIA SWINE VACCINES MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 299. ITALY SWINE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 300. ITALY SWINE VACCINES MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 301. ITALY SWINE VACCINES MARKET SIZE, BY ANIMAL AGE, 2018-2024 (USD MILLION)
TABLE 302. ITALY SWINE VACCINES MARKET SIZE, BY ANIMAL AGE, 2025-2030 (USD MILLION)
TABLE 303. ITALY SWINE VACCINES MARKET SIZE, BY BREEDERS, 2018-2024 (USD MILLION)
TABLE 304. ITALY SWINE VACCINES MARKET SIZE, BY BREEDERS, 2025-2030 (USD MILLION)
TABLE 305. ITALY SWINE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 306. ITALY SWINE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 307. ITALY SWINE VACCINES MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 308. ITALY SWINE VACCINES MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 309. ITALY SWINE VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 310. ITALY SWINE VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 311. ITALY SWINE VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
TABLE 312. ITALY SWINE VACCINES MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
TABLE 313. ITALY SWINE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 314. ITALY SWINE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 315. ITALY SWINE VACCINES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 316. ITALY SWINE VACCINES MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 317. SPAIN SWINE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 318. SPAIN SWINE VACCINES MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 319. SPAIN SWINE VACCINES MARKET SIZE, BY ANIMAL AGE, 2018-2024 (USD MILLION)
TABLE 320. SPAIN SWINE VACCINES MARKET SIZE, BY ANIMAL AGE, 2025-2030 (USD MILLION)
TABLE 321. SPAIN SWINE VACCINES MARKET SIZE, BY BREEDERS, 2018-2024 (USD MILLION)
TABLE 322. SPAIN SWINE VACCINES MARKET SIZE, BY BREEDERS, 2025-2030 (USD MILLION)
TABLE 323. SPAIN SWINE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 324. SPAIN SWINE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 325. SPAIN SWINE VACCINES MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 326. SPAIN SWINE VACCINES MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 327. SPAIN SWINE VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 328. SPAIN SWINE VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 329. SPAIN SWINE VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
TABLE 330. SPAIN SWINE VACCINES MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
TABLE 331. SPAIN SWINE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 332. SPAIN SWINE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 333. SPAIN SWINE VACCINES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 334. SPAIN SWINE VACCINES MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 335. UNITED ARAB EMIRATES SWINE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 336. UNITED ARAB EMIRATES SWINE VACCINES MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 337. UNITED ARAB EMIRATES SWINE VACCINES MARKET SIZE, BY ANIMAL AGE, 2018-2024 (USD MILLION)
TABLE 338. UNITED ARAB EMIRATES SWINE VACCINES MARKET SIZE, BY ANIMAL AGE, 2025-2030 (USD MILLION)
TABLE 339. UNITED ARAB EMIRATES SWINE VACCINES MARKET SIZE, BY BREEDERS, 2018-2024 (USD MILLION)
TABLE 340. UNITED ARAB EMIRATES SWINE VACCINES MARKET SIZE, BY BREEDERS, 2025-2030 (USD MILLION)
TABLE 341. UNITED ARAB EMIRATES SWINE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 342. UNITED ARAB EMIRATES SWINE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 343. UNITED ARAB EMIRATES SWINE VACCINES MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 344. UNITED ARAB EMIRATES SWINE VACCINES MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 345. UNITED ARAB EMIRATES SWINE VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 346. UNITED ARAB EMIRATES SWINE VACCINES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 347. UNITED ARAB EMIRATES SWINE VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
TABLE 348. UNITED ARAB EMIRATES SWINE VACCINES MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
TABLE 349. UNITED ARAB EMIRATES SWINE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 350. UNITED ARAB EMIRATES SWINE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 351. UNITED ARAB EMIRATES SWINE VACCINES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 352. UNITED ARAB EMIRATES SWINE VACCINE

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Swine Vaccines market report include:
  • Zoetis Inc.
  • Merck & Co., Inc.
  • Boehringer Ingelheim Animal Health GmbH
  • Elanco Animal Health Incorporated
  • Ceva Santé Animale SAS
  • Virbac S.A.
  • Vetoquinol S.A.
  • HIPRA, S.A.
  • Phibro Animal Health Corporation
  • IDT Biologika GmbH

Table Information